Literature DB >> 20193825

Diabetic retinopathy: An update on treatment.

Ryan J Fante1, Vikram D Durairaj, Scott C N Oliver.   

Abstract

Diabetic retinopathy is a progressive disease that results from vascular injury due to chronic hyperglycemia. It is the leading cause of blindness in working-age adults in the US and is usually asymptomatic until late stages. Treatment with laser photocoagulation is effective at preventing severe vision loss; thus, diabetic patients should be referred for regular screening by an ophthalmologist. New inhibitors of vascular endothelial growth factor may provide targeted nonsurgical treatment to improve vision in diabetic retinopathy. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20193825     DOI: 10.1016/j.amjmed.2009.09.020

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.

Authors:  Eun-Ah Ye; Li Liu; Jena J Steinle
Journal:  Vision Res       Date:  2017-08-07       Impact factor: 1.886

2.  Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein.

Authors:  Xi-Yu Mei; Ling-Yu Zhou; Tian-Yu Zhang; Bin Lu; Li-Li Ji
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

3.  MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

Authors:  Li-Li Qin; Mei-Xia An; Yan-Li Liu; Han-Chun Xu; Zhi-Qing Lu
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

4.  Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats.

Authors:  Yan Lu; Nan Zhou; Xiao Huang; Jin-Wei Cheng; Feng-Qian Li; Rui-Li Wei; Ji-Ping Cai
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

5.  Protein kinase C activation affects, via the mRNA-binding Hu-antigen R/ELAV protein, vascular endothelial growth factor expression in a pericytic/endothelial coculture model.

Authors:  M Amadio; C Osera; G Lupo; C Motta; F Drago; S Govoni; A Pascale
Journal:  Mol Vis       Date:  2012-08-01       Impact factor: 2.367

6.  The eye as a window to rare endocrine disorders.

Authors:  Rupali Chopra; Ashish Chander; Jubbin J Jacob
Journal:  Indian J Endocrinol Metab       Date:  2012-05

7.  Glucose and fluoxetine induce fine structural change in human serum albumin.

Authors:  Minoo Shahani; Fatemeh Daneshi-Mehr; Roya Tadayon; Behrooz Hoseinzade Salavati; Ali-Reza Akbar Zadeh-Baghban; Abbas Zamanian; Mostafa Rezaei-Tavirani
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

8.  Rates and Predictors of Nonadherence to Postophthalmic Screening Tertiary Referrals in Patients with Type 2 Diabetes.

Authors:  Josh Tjunrong Sia; Alfred Tau Liang Gan; BaoLin Pauline Soh; Eva Fenwick; Joanne Quah; Thakur Sahil; Yijin Tao; Ngiap Chuan Tan; Charumathi Sabanayagam; Ecosse L Lamoureux; Ryan Eyn Kidd Man
Journal:  Transl Vis Sci Technol       Date:  2020-05-19       Impact factor: 3.283

9.  Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells.

Authors:  Huaisheng Zhou; Liqun Yang; Huajie Li; Haijun Gong; Liangzheng Cheng; Haisheng Zheng; Li-Ming Zhang; Yuqing Lan
Journal:  Int J Nanomedicine       Date:  2012-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.